Inventor profile of:

Robert T. Lyons

City:

Laguna Hills, California

Country:

United States

Published Applications:

52

Last publication date:

2022-04-07

Top Assignees for applications by Robert T. Lyons

The entities that hold a legal rights for patent applications filed by inventor Lyons Robert T.:

Recent patent applications by Lyons Robert T.

Robert T. Lyons from Laguna Hills, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-04-07
US20220106388A1
Chemistry; metallurgy

HIGH VISCOSITY MACROMOLECULAR COMPOSITIONS FOR TREATING OCULAR CONDITIONS

#2 | 2021-08-19
US20210251961A1
Human necessities

COMPOSITIONS FOR DELIVERY OF THERAPEUTICS INTO THE EYES AND METHODS FOR MAKING AND USING SAME

#3 | 2015-10-08
US20150283240A1
Human necessities

STABILIZED COMPOSITIONS COMPRISING A THERAPEUTICALLY ACTIVE AGENT AND AN OXIDIZING PRESERVATIVE

#4 | 2015-06-25
US20150174062A1
Human necessities

BIODEGRADABLE DRUG DELIVERY SYSTEM

#5 | 2015-06-18
US20150164863A1
Human necessities

COMPOSITIONS FOR DELIVERY OF THERAPEUTICS INTO THE EYES AND METHODS FOR MAKING AND USING SAME

#6 | 2015-05-21
US20150141484A1
Human necessities

Methods, Compositions and Drug Delivery Systems for Intraocular Delivery of siRNA Molecules

#7 | 2014-12-04
US20140356438A1
Human necessities

Peripherally administered viscous formulations

#8 | 2014-02-20
US20140051671A1
Human necessities

Pharmaceutical compositions

#9 | 2013-11-07
US20130296396A1
Human necessities

Compositions for delivery of therapeutics into the eyes and methods for making and using same

#10 | 2013-10-24
US20130280272A1
Human necessities

Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier

#11 | 2013-06-06
US20130144252A1
Human necessities

NEEDLESS MICROPROTRUSION ELASTOPLAST SYSTEM

#12 | 2013-04-11
US20130090387A1
Human necessities

Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative

#13 | 2013-02-07
US20130034550A1
Human necessities

Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier

#14 | 2012-11-08
US20120283232A9
Human necessities

PROCESS FOR MAKING A PHARMACEUTICAL COMPOSITION

#15 | 2012-10-18
US20120263779A1
Human necessities

Biodegradable drug delivery system

#16 | 2012-01-05
US20120003230A1
Human necessities

Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier

#17 | 2010-12-09
US20100311808A1
Human necessities

Methods, compositions and drug delivery systems for intraocular delivery of siRNA molecules

#18 | 2009-10-15
US20090258924A1
Human necessities

METHODS, COMPOSITIONS AND DRUG DELIVERY SYSTEMS FOR INTRAOCULAR DELIVERY OF siRNA MOLECULES

#19 | 2009-09-10
US20090226531A1
Human necessities

METHODS AND COMPOSITION FOR INTRAOCULAR DELIVERY OF THERAPEUTIC SIRNA

#20 | 2009-08-13
US20090203660A1
Human necessities

Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

#21 | 2009-08-06
US20090197847A1
Human necessities

Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

#22 | 2009-08-06
US20090197846A1
Human necessities

Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

#23 | 2009-06-18
US20090156568A1
Human necessities

Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

#24 | 2009-06-11
US20090149435A1
Human necessities

PROCESS FOR MAKING A PHARMACEUTICAL COMPOSITION

#25 | 2009-05-07
US20090118247A1
Human necessities

Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

#26 | 2009-05-07
US20090118246A1
Human necessities

Therapeutic ophthalmic compositions containing retinal friendly recpients and related methods

#27 | 2008-12-04
US20080300315A1
Human necessities

Stabilized compositions comprising a therapeutically active agent, and an oxidizing preservative

#28 | 2008-11-27
US20080292679A1
Human necessities

Biodegradable drug delivery system

#29 | 2008-10-30
US20080269181A1
Human necessities

Methods for treating a posterior segment of an eye

#30 | 2008-10-30
US20080268051A1
Chemistry; metallurgy

High viscosity macromolecular compositions for treating ocular conditions

#31 | 2008-10-02
US20080241252A1
Human necessities

Methods and compositions for intraocular administration to treat ocular conditions

#32 | 2008-09-11
US20080221524A1
Human necessities

NEEDLELESS MICROPROTRUSION ELASTOPLAST SYSTEM

#33 | 2008-05-08
US20080107694A1
Human necessities

Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier

#34 | 2008-04-24
US20080097335A1
Human necessities

OCULAR IMPLANT DELIVERY ASSEMBLIES

#35 | 2008-02-21
US20080044476A1
Human necessities

Peripherally administered viscous formulations

#36 | 2008-02-07
US20080033351A1
Human necessities

Ocular implant delivery assemblies with distal caps

#37 | 2007-09-27
US20070224278A1
Human necessities

LOW IMMUNOGENICITY CORTICOSTEROID COMPOSITIONS

#38 | 2007-09-20
US20070218007A1
Human necessities

Ophthalmic visualization compositions and methods of using same

#39 | 2007-05-03
US20070098774A1
Human necessities

Method of delivering a medication

#40 | 2007-05-03
US20070098773A1
Human necessities

Needleless microprotrusion elastoplast system

#41 | 2006-08-17
US20060182783A1
Human necessities

Sustained release intraocular drug delivery systems

#42 | 2006-06-29
US20060141049A1
Human necessities

Triamcinolone compositions for intravitreal administration to treat ocular conditions

#43 | 2006-05-11
US20060100584A1
Human necessities

Needleless microprotrusion elastoplast system

#44 | 2006-05-04
US20060094700A1
Human necessities

Heat sterilization of a steroid in the presence of phosphate

#45 | 2005-12-15
US20050276867A1
Human necessities

Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative

#46 | 2005-11-17
US20050256083A1
Human necessities

Preserved pharmaceutical compositions comprising cyclodextrins

#47 | 2005-11-10
US20050250737A1
Human necessities

Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods

#48 | 2005-10-20
US20050234018A1
Human necessities

Drug delivery to the back of the eye

#49 | 2005-05-12
US20050101582A1
Human necessities

Compositions and methods for treating a posterior segment of an eye

#50 | 2005-03-29
US9904753
-

Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions

#51 | 2005-02-10
US20050031697A1
Human necessities

Compositions for delivery of therapeutics into the eyes and methods for making and using same

#52 | 2005-01-06
US20050004074A1
Human necessities

Inhibition of irritating side effects associated with use of a topical ophthalmic medication

InventorID:

78030 ⎘